Drug
Dexmedetomidine-esketamine combination
Dexmedetomidine-esketamine combination is a pharmaceutical drug with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
3(60%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
40%
Ph phase_4
3
60%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(4)
Completed(1)
Detailed Status
Recruiting3
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (60.0%)
N/A2 (40.0%)
Trials by Status
recruiting360%
not_yet_recruiting120%
completed120%
Recent Activity
3 active trials
Showing 5 of 5
recruitingphase_4
Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients
NCT07151716
not_yet_recruitingnot_applicable
Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients
NCT06468436
completednot_applicable
Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation
NCT06003218
recruitingphase_4
Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery
NCT06859892
recruitingphase_4
Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA
NCT06566482
Clinical Trials (5)
Showing 5 of 5 trials
NCT07151716Phase 4
Sedation With Dexmedetomidine-esketamine Combination and Delirium in ICU Patients
NCT06468436Not Applicable
Dexmedetomidine-Esketamine Combination for Sedation and Analgesia in ICU Patients
NCT06003218Not Applicable
Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation
NCT06859892Phase 4
Dexmedetomidine-Esketamine Combination and Sleep Disturbances After Major Noncardiac Surgery
NCT06566482Phase 4
Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5